ECSP15034601A - Composiciones nutricionales que contienen treonato de magnesio, y sus usos - Google Patents

Composiciones nutricionales que contienen treonato de magnesio, y sus usos

Info

Publication number
ECSP15034601A
ECSP15034601A ECIEPI201534601A ECPI201534601A ECSP15034601A EC SP15034601 A ECSP15034601 A EC SP15034601A EC IEPI201534601 A ECIEPI201534601 A EC IEPI201534601A EC PI201534601 A ECPI201534601 A EC PI201534601A EC SP15034601 A ECSP15034601 A EC SP15034601A
Authority
EC
Ecuador
Prior art keywords
magnesium threonate
compositions containing
containing magnesium
nutritional composition
nutritional compositions
Prior art date
Application number
ECIEPI201534601A
Other languages
English (en)
Inventor
Brian Berg
Original Assignee
Zaner Bloser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49887325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP15034601(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zaner Bloser Inc filed Critical Zaner Bloser Inc
Publication of ECSP15034601A publication Critical patent/ECSP15034601A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente revelación se refiere composición(es) nutricional(es) que comprende(n) una fuente de carbohidratos, una fuente de proteínas, una fuente de grasa y treonato de magnesio. El treonato magnesio puede proporcionar beneficios neurológicos para la salud cuando se consume. La relevación se refiere además a métodos de promoción de la salud neurológica proporcionando una composición nutricional que comprende treonato de magnesio. Además, la revelación se refiere a métodos para promover la tolerancia GI en un sujeto pediátrico proporcionando una composición nutricional que comprende treonato de magnesio.
ECIEPI201534601A 2013-01-11 2015-08-11 Composiciones nutricionales que contienen treonato de magnesio, y sus usos ECSP15034601A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/739,813 US9301966B2 (en) 2013-01-11 2013-01-11 Nutritional compositions containing magnesium threonate and uses thereof
PCT/US2013/074539 WO2014109863A1 (en) 2013-01-11 2013-12-12 Nutritional compositions containing magnesium threonate and uses thereof

Publications (1)

Publication Number Publication Date
ECSP15034601A true ECSP15034601A (es) 2015-11-30

Family

ID=49887325

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201534601A ECSP15034601A (es) 2013-01-11 2015-08-11 Composiciones nutricionales que contienen treonato de magnesio, y sus usos

Country Status (18)

Country Link
US (1) US9301966B2 (es)
EP (1) EP2943081B1 (es)
CN (2) CN104883911A (es)
AU (1) AU2013372899B2 (es)
BR (1) BR112015011931A2 (es)
CA (1) CA2897776A1 (es)
EC (1) ECSP15034601A (es)
ES (1) ES2649715T3 (es)
HK (1) HK1214091A1 (es)
MX (1) MX366527B (es)
MY (1) MY170033A (es)
NO (1) NO2967044T3 (es)
PE (1) PE20151806A1 (es)
PH (1) PH12015501688B1 (es)
PL (1) PL2943081T3 (es)
RU (1) RU2015122495A (es)
SG (1) SG11201503753XA (es)
WO (1) WO2014109863A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
CN108463122A (zh) * 2015-12-14 2018-08-28 雀巢产品技术援助有限公司 用于促进脑的髓鞘形成的营养组合物和婴儿配方食品
CN106333366A (zh) * 2016-09-28 2017-01-18 张家港威胜生物医药有限公司 一种具有抗疲劳作用的组合物及其制备方法与用途
CN110891982B (zh) 2017-04-17 2023-12-22 芝加哥大学 向肠道递送短链脂肪酸以用于人体保健和疾病治疗的聚合物材料
WO2018200885A1 (en) 2017-04-26 2018-11-01 Neurocentria, Inc. Magnesium compositions and methods of use
CN109845877B (zh) * 2017-11-30 2022-07-12 内蒙古伊利实业集团股份有限公司 一种水解蛋白脱苦组合物及其产品、制备和应用
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2022157798A1 (en) * 2021-01-22 2022-07-28 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for treating neurocognitive disorders
CN115868628B (zh) * 2022-10-11 2024-01-26 泓博元生命科技（深圳）有限公司 减肥组合物
CN115894216A (zh) * 2022-12-19 2023-04-04 浦拉司科技（上海）有限责任公司 一种l-苏糖酸镁的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101742998B (zh) 2007-03-22 2014-09-17 玛格塞蒂克斯公司 镁组合物及其用途
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
WO2010047581A1 (en) * 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition
EP2251031A1 (en) * 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
WO2011003045A1 (en) * 2009-07-01 2011-01-06 Magceutics, Inc. Slow release magnesium composition and uses thereof
US8648036B2 (en) 2010-12-29 2014-02-11 Mead Johnson Nutrition Company Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20130095204A1 (en) 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
RU2015122495A (ru) 2017-02-17
AU2013372899A1 (en) 2015-05-28
HK1214091A1 (zh) 2016-07-22
PL2943081T3 (pl) 2018-03-30
PH12015501688A1 (en) 2015-10-19
CN110101079A (zh) 2019-08-09
EP2943081A1 (en) 2015-11-18
NO2967044T3 (es) 2018-06-02
US20140200176A1 (en) 2014-07-17
AU2013372899B2 (en) 2016-12-08
US9301966B2 (en) 2016-04-05
PE20151806A1 (es) 2015-12-17
BR112015011931A2 (pt) 2017-07-11
EP2943081B1 (en) 2017-10-04
MX2015008583A (es) 2015-09-04
ES2649715T3 (es) 2018-01-15
PH12015501688B1 (en) 2015-10-19
SG11201503753XA (en) 2015-06-29
CA2897776A1 (en) 2014-07-17
CN104883911A (zh) 2015-09-02
MX366527B (es) 2019-07-12
MY170033A (en) 2019-06-26
WO2014109863A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
ECSP15034601A (es) Composiciones nutricionales que contienen treonato de magnesio, y sus usos
AR102148A1 (es) Composiciones y combinaciones para uso como suplementos alimenticios para animales
GT201500081A (es) Derivados de exendina-4 como agonistas duales de glp1/glucagón
CR20130411A (es) Composiciones de puré que tienen proporciones de carbohidrato específicas y los métodos para utilizar las mismas
EA201491323A1 (ru) Способ кормления
WO2015034812A3 (en) A new ketogenic diet and its use in treating the critically ill
PE20171076A1 (es) Composicion que contiene quitina y proteinas digeribles
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
GT201600002A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
EA201592085A1 (ru) Применение жирной кислоты таллового масла
BR112015019578A2 (pt) composição para uso farmacêutico com atividade antioxidante contra radicais livres, uso cosmético de uma composição para produzir atividade antioxidante contra radicais livres e uso nutricional dietético de uma composição para produzir atividade antioxidante contra radicais livres
BR112013027403A2 (pt) composições que compreendem uma antimetabólito de glicose e selênio
ECSP13012799A (es) Uso de composiciones nutricionales que incluyen lactoferrinas para mejorar la resistencia a enfermedades y condiciones
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
BR112015033057A2 (pt) Elemento de torção transmissivo com resposta elástica
MX2015012205A (es) Productos de leche humana altos en grasa.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
ZA201702977B (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses.
AR095383A1 (es) Composición nutricional anti-regurgitación
BR112015001616B8 (pt) Método para aumento do teor de sus em um óleo ou em uma fração de oleína por intraesterificação 1,3-específica, óleo ou oleína intraesterificado 1,3-seletivo e seu uso
PH12015502242A1 (en) Lutein composition suitable for infant food formulations
BR112016006990A2 (pt) composição de óleo e gordura para chocolate do tipo não temperado e composição de óleo e gordura para chocolate do tipo temperado
CR20130562A (es) Etiqueta adhesiva inteligente nanotecnológica para ser utilizada con alimentos perecederos
BR112015023730A2 (pt) uso de sedoeptulose como suplemento nutricional
MY174193A (en) Selective transfer hydrogenation of citral or ethyl citral